Publications by authors named "Sandra D Comer"

Claim this Profile
B
Behavioural Effects and Naloxone Effectiveness With New Synthetic Opioids.
Suzanne Nielsen, João Pedro Silva, Jermaine D Jones, Alex Krotulski, Dilkushi Poovendran, Sandra D Comer

Drug Alcohol Rev· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polysubstance use in pregnancy: Findings from a population-based cross-sectional cohort study of pregnant women with opioid use.
Rachel Luba, Sandra D Comer, Lena Sun, Samuel D Pimentel, Sherian Li

Drug Alcohol Depend· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abuse potential assessment of novel central nervous system active and psychedelic substances for controlled substances act scheduling recommendations.
Jack E Henningfield, Sandra D Comer, Matthew L Banks, Marion A Coe, Gregory T Collins

J Psychopharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonpharmacological and pharmacological influences on opioid effects: A review of clinical research findings.
Rachel Luba, Sandra D Comer

J Pharmacol Exp Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of vaped cannabis on the severity of naloxone-precipitated opioid withdrawal.
Jermaine D Jones, Suky Martinez, Caroline Arout, Margaret Haney, Felipe Castillo, Sandra D Comer

Exp Clin Psychopharmacol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of Fentanyl Exposure in Emergency Department Patients With Illicit Drug Use.
Dana L Sacco, Marc A Probst, Zachary L Mannes, Sandra D Comer, Silvia S Martins

Ann Emerg Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Abuse Potential of Lenabasum, a Selective Cannabinoid Receptor 2 Agonist.
Rachel Luba, Gabriela Madera, Rebecca Schusterman, Andrew Kolodziej, Ian Hodgson, Sandra D Comer

J Pharmacol Exp Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opioid vaccine clinical testing: lessons learned.
Rachel Luba, Sandra D Comer

Curr Opin Psychiatry· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended-Release Injection vs Sublingual Buprenorphine for Opioid Use Disorder With Fentanyl Use: A Post Hoc Analysis of a Randomized Clinical Trial.
Edward V Nunes, Sandra D Comer, Michelle R Lofwall, Sharon L Walsh, Stefan Peterson

JAMA Netw Open· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder.
Sharon L Walsh, Sandra D Comer, Jurij Aguiar Zdovc, Céline Sarr, Marcus Björnsson

Neuropsychopharmacology· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Will the promise of translational neuropsychopharmacology research ever deliver? The lion's roar; the kitten's purr.
Jacqueline F McGinty, Victoria Arango, Kathleen T Brady, Sandra D Comer, Rita Z Goldstein

NPP Digit Psychiatry Neurosci· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Implications of the Relationship Between Naltrexone Plasma Levels and the Subjective Effects of Heroin in Humans.
Felipe Castillo, Hannah M Harris, Dania Lerman, Adam Bisaga, Edward V Nunes, Sandra D Comer

J Addict Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are you thinking what I'm thinking? Defining what we mean by "polysubstance use.".
Amanda M Bunting, Riley Shearer, Ashley N Linden-Carmichael, Arthur Robin Williams, Sandra D Comer

Am J Drug Alcohol Abuse· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: Effects of selective dopamine D3 receptor partial agonist/antagonists on oxycodone self-administration and antinociception in monkeys.
Samantha Chong, Sandra D Comer

Neuropsychopharmacology· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of a Protective Behavioral Strategies Scale for Individuals who use Opioids: Preliminary Findings and Future Directions.
Rachel Luba, Manesh Gopaldas, Suky Martinez, Sandra D Comer

Res Sq· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No evidence of accelerated epigenetic aging among black heroin users: A case vs control analysis.
Jermaine D Jones, Suky Martinez, Ingrid Gonzalez, Gabriel J Odom, Sandra D Comer

Addict Neurosci· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study investigating cognitive impairment associated with opioid overdose.
James J Mahoney, Erin L Winstanley, Felipe Castillo, Rachel Luba, Jennifer Marton, Sandra D Comer

Drug Alcohol Depend· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of diagnostic codes for prenatal opioid exposure and neonatal opioid withdrawal syndrome.
Michael W Kuzniewicz, Cynthia I Campbell, Sherian Li, Eileen M Walsh, Lisa A Croen, Sandra D Comer

J Perinatol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential role of opioid vaccines and monoclonal antibodies in the opioid overdose crisis.
Suky Martinez, Hannah Harris, Thomas Chao, Rachel Luba, Marco Pravetoni, Sandra D Comer

Expert Opin Investig Drugs· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review.
Brian D Kiluk, Bethea A Kleykamp, Sandra D Comer, Roland R Griffiths, Andrew S Huhn

JAMA Psychiatry· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sublingual dexmedetomidine (BXCL501) reduces opioid withdrawal symptoms: findings from a multi-site, phase 1b/2, randomized, double-blind, placebo-controlled trial.
Jermaine D Jones, Lavanya Rajachandran, Frank Yocca, Robert Risinger, Michael De Vivo, Sandra D Comer

Am J Drug Alcohol Abuse· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapeutic strategies for treating opioid use disorder and overdose.
Rachel Luba, Suky Martinez, Jermaine Jones, Marco Pravetoni, Sandra D Comer

Expert Opin Investig Drugs· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The subjective experience of heroin effects among individuals with chronic opioid use: Revisiting reinforcement in an exploratory study.
Suky Martinez, Laura Brandt, Sandra D Comer, Frances R Levin, Jermaine D Jones

Addict Neurosci· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.
Jack E Henningfield, Marion A Coe, Roland R Griffiths, Sean J Belouin, Ann Berger, Sandra D Comer

Neuropharmacology· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel long-acting formulation of oral buprenorphine/naloxone produces prolonged decreases in fentanyl self-administration by rhesus monkeys.
Richard W Foltin, Stephen Zale, Kristine A Sykes, Nayana Nagaraj, Richard E Scranton, Sandra D Comer

Drug Alcohol Depend· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis